Effects of Exercise in Patients With Ulcerative Colitis
Primary Purpose
Ulcerative Colitis, Inflammatory Bowel Diseases
Status
Suspended
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Exercise
Sponsored by
About this trial
This is an interventional basic science trial for Ulcerative Colitis focused on measuring Ulcerative Colitis, Inflammatory Bowel Disease, Exercise, Gastric emptying rate, Inflammatory markers, Gastrointestinal integrity
Eligibility Criteria
Inclusion Criteria:
For ulcerative colitis patients;
- Currently in remission of disease (asymptomatic at time of experiment)
- Less than 3 periods of disease activity (periods of symptomatic activity) in the last 12 months
- No history of surgery to alleviate condition severity
- Taking regular standard medication for control of condition
- Adult less than 50 years due to effects of exercise in older age
- Non-smokers
- Regular exercisers (determined via verbal discussion)
For healthy controls;
- No history of disease (as assessed by standard medical screening questionnaire)
- Adult less than 50 years due to effects of exercise in older age
- Non-smokers
- Regular exercisers (determined via verbal discussion)
Exclusion Criteria:
For ulcerative colitis patients;
- Currently in active period of disease (symptomatic at time of experiment)
- More than 3 periods of disease activity (periods of symptomatic activity) in the last 12 months
- History of surgery to alleviate condition severity
- Taking non-standard medication for control of condition
- Adult more than 50 years of age
- Under 18 years of age
- Smokers
- Sedentary or not regularly physically active (determined via verbal discussion)
For healthy controls;
- History of disease (as assessed by standard medical screening questionnaire)
- Adult more than 50 years of age
- Under 18 years of age
- Smokers
- Sedentary or not regularly physically active (determined via verbal discussion)
Sites / Locations
- Manchester Metropolitan University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
UC Patients
Healthy controls
Arm Description
Patient group
Control group
Outcomes
Primary Outcome Measures
Change in inflammatory markers or hormones
Circulating concentrations of Interleukin-6, Tumor Necrosis Factor-alpha, C-reactive protein, glucagon like peptide 2
Area under the circulating concentration versus time curve (AUC) of inflammatory markers or hormones
Responses of Interleukin-6, Tumor Necrosis Factor-alpha, C-reactive protein, glucagon like peptide 2
Change in intestinal epithelial damage and permeability markers
Circulating concentrations of intestinal fatty acid binding protein and claudin-3
Area under the circulating concentration versus time curve (AUC) of intestinal epithelial damage and permeability markers
Responses of intestinal fatty acid binding protein and claudin-3
Change in exercise induced endotoxaemia markers
Circulating concentrations of plasma lipopolysaccharide
Area under the circulating concentration versus time curve (AUC) of exercise induced endotoxaemia markers
Response of plasma lipopolysaccharide
Gastric emptying rate half time and time of maximal emptying rate
Emptying rate of a commercially available sports drink from the stomach using the 13C breath test method
Change in ratio of 13C/12C in breath samples
Gastric emptying profile of a commercially available sports drink from the stomach using the 13C breath test method
Secondary Outcome Measures
Incidence and severity of gastrointestinal symptoms
10-point rating scale for gastrointestinal symptoms (Visual Analogue Scale modified). 19 item questionnaire with 5 subcategories (Overall gut discomfort, total gastrointestinal symptoms, upper gastrointestinal symptoms, lower gastrointestinal symptoms and other gastrointestinal symptoms). Scores for each item ranging from 0 (no symptom) to 10 (extremely severe symptoms causing exercise reduction, stopping, or complete withdrawal). Higher scores represent higher severity of symptoms.
Heart rate response
Heart rate telemetry
Disparity of subjective exertion and objective cardiorespiratory parameters
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and cardiopulmonary exercise testing variables of oxygen uptake, carbon dioxide expiration, ventilatory threshold, volume of air expired, and tidal volume (all parameters measured in L/min).
Disparity of subjective exertion and objective heart rate
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and heart rate measured by telemetry
Disparity of subjective exertion and breathing frequency
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and number of breaths per minute
Disparity of subjective exertion and oxygen pulse
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and oxygen pulse calculated by dividing oxygen uptake by heart rate.
Disparity of subjective exertion and respiratory exchange ratio
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and respiratory exchange ratio calculated by dividing carbon dioxide production by oxygen uptake.
Disparity of subjective exertion and ventilatory efficiency
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and minute ventilation/carbon dioxide slope (VE/VCO2 slope).
Subjective physical activity levels
International Physical Activity Questionnaire (IPAQ). Answers to questions (time spent completing different physical activities) converted to Metabolic Equivalent (METs) hours per week. Minimum value of zero, no limit to maximum. Higher MET values indicate higher physical activity levels.
Attitudes and beliefs towards physical activity
Barriers to Physical Activity Questionnaire. 21 item questionnaire, each question rated from 0 (very unlikely) to 3 (very likely). Each item belongs to one of 7 categories relating to barriers to physical activity. Score totals greater than 5 indicate the category as being a significant barrier.
Subjective health related quality of life: RAND 36-Item Short Form Health Survey (SF-36)
RAND 36-Item Short Form Health Survey (SF-36). 36-item questionnaire covering 8 concepts; physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions, plus single item providing an indication of perceived change in health. Scores ranging from 0 to 100 for each concept with 100 indicating good health and 0 being poor health.
Full Information
NCT ID
NCT04143490
First Posted
October 15, 2019
Last Updated
January 4, 2023
Sponsor
Manchester Metropolitan University
Collaborators
University of Manchester
1. Study Identification
Unique Protocol Identification Number
NCT04143490
Brief Title
Effects of Exercise in Patients With Ulcerative Colitis
Official Title
The Effects of Exercise Intensity on Gastrointestinal Function and Inflammatory Markers in Patients With Ulcerative Colitis
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Suspended
Why Stopped
Due to Covid-19
Study Start Date
November 4, 2019 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
December 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Manchester Metropolitan University
Collaborators
University of Manchester
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to investigate the effects of moderate to high intensity exercise on gut function and inflammatory markers in patients with Ulcerative Colitis (UC), and to compare them with individuals of matched age who do not suffer from Inflammatory Bowel Disease. Participants will be asked to complete 60 minutes of continuous cycling at a moderate to high intensity followed by a three hour recovery period. Gastrointestinal function will be measured using a non-invasive breath test. Blood samples will be collected at multiple time-points during the visit and these samples will be measured for markers of immune function and intestinal integrity.
Detailed Description
There is limited research on the effect of exercise on patients with Ulcerative Colitis. The aim of this investigation is to study the acute effects of moderate to high intensity exercise on gut function in patients with Ulcerative Colitis and to compare them with individuals of matched age who do not suffer from Inflammatory Bowel Disease.
Patients in remission from disease activity and age and gender matched healthy control participants will be recruited from the general population. Participants will attend the laboratory on two occasions. The first visit will last approximately one hour and will include an exercise test to determine peak oxygen uptake capacity (VO2peak) which is an indicator of cardiorespiratory fitness. The second visit will last for approximately four and a half hours and will consist of a 60 minute continuous cycle on a stationary cycle ergometer at an intensity of 65% VO2peak followed by a recovery period. Gastric emptying rate of a commercially available sports drink will be measured and blood samples will be collected at regular time-points throughout the visit and analysed for concentrations of inflammatory markers and intestinal integrity/function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis, Inflammatory Bowel Diseases
Keywords
Ulcerative Colitis, Inflammatory Bowel Disease, Exercise, Gastric emptying rate, Inflammatory markers, Gastrointestinal integrity
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Single experimental trial with a UC patient group and an age and gender matched healthy control group
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
UC Patients
Arm Type
Experimental
Arm Description
Patient group
Arm Title
Healthy controls
Arm Type
Active Comparator
Arm Description
Control group
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
60 minutes of continuous exercise at 65% VO2peak and drink ingestion
Primary Outcome Measure Information:
Title
Change in inflammatory markers or hormones
Description
Circulating concentrations of Interleukin-6, Tumor Necrosis Factor-alpha, C-reactive protein, glucagon like peptide 2
Time Frame
6 blood samples collected at baseline, 30 minutes of exercise (mid exercise), immediately post exercise bout, then every 60 minutes post exercise for 3 hours
Title
Area under the circulating concentration versus time curve (AUC) of inflammatory markers or hormones
Description
Responses of Interleukin-6, Tumor Necrosis Factor-alpha, C-reactive protein, glucagon like peptide 2
Time Frame
4.5 hours
Title
Change in intestinal epithelial damage and permeability markers
Description
Circulating concentrations of intestinal fatty acid binding protein and claudin-3
Time Frame
6 blood samples collected at baseline, 30 minutes of exercise (mid exercise), immediately post exercise bout, then every 60 minutes post exercise for 3 hours
Title
Area under the circulating concentration versus time curve (AUC) of intestinal epithelial damage and permeability markers
Description
Responses of intestinal fatty acid binding protein and claudin-3
Time Frame
4.5 hours
Title
Change in exercise induced endotoxaemia markers
Description
Circulating concentrations of plasma lipopolysaccharide
Time Frame
6 blood samples collected at baseline, 30 minutes of exercise (mid exercise), immediately post exercise bout, then every 60 minutes post exercise for 3 hours
Title
Area under the circulating concentration versus time curve (AUC) of exercise induced endotoxaemia markers
Description
Response of plasma lipopolysaccharide
Time Frame
4.5 hours
Title
Gastric emptying rate half time and time of maximal emptying rate
Description
Emptying rate of a commercially available sports drink from the stomach using the 13C breath test method
Time Frame
2 hours after ingestion of drink
Title
Change in ratio of 13C/12C in breath samples
Description
Gastric emptying profile of a commercially available sports drink from the stomach using the 13C breath test method
Time Frame
9 breath samples collected at baseline, then every 15 minutes after ingestion for 2 hours
Secondary Outcome Measure Information:
Title
Incidence and severity of gastrointestinal symptoms
Description
10-point rating scale for gastrointestinal symptoms (Visual Analogue Scale modified). 19 item questionnaire with 5 subcategories (Overall gut discomfort, total gastrointestinal symptoms, upper gastrointestinal symptoms, lower gastrointestinal symptoms and other gastrointestinal symptoms). Scores for each item ranging from 0 (no symptom) to 10 (extremely severe symptoms causing exercise reduction, stopping, or complete withdrawal). Higher scores represent higher severity of symptoms.
Time Frame
Immediately post-exercise bout and 3 hours post exercise.
Title
Heart rate response
Description
Heart rate telemetry
Time Frame
Every 5 minutes during 60 minute cycle
Title
Disparity of subjective exertion and objective cardiorespiratory parameters
Description
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and cardiopulmonary exercise testing variables of oxygen uptake, carbon dioxide expiration, ventilatory threshold, volume of air expired, and tidal volume (all parameters measured in L/min).
Time Frame
Every minute during the peak oxygen uptake test that typically lasts between 8-12 minutes
Title
Disparity of subjective exertion and objective heart rate
Description
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and heart rate measured by telemetry
Time Frame
Every minute during the peak oxygen uptake test that typically lasts between 8-12 minutes
Title
Disparity of subjective exertion and breathing frequency
Description
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and number of breaths per minute
Time Frame
Every minute during the peak oxygen uptake test that typically lasts between 8-12 minutes
Title
Disparity of subjective exertion and oxygen pulse
Description
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and oxygen pulse calculated by dividing oxygen uptake by heart rate.
Time Frame
Every minute during the peak oxygen uptake test that typically lasts between 8-12 minutes
Title
Disparity of subjective exertion and respiratory exchange ratio
Description
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and respiratory exchange ratio calculated by dividing carbon dioxide production by oxygen uptake.
Time Frame
Every minute during the peak oxygen uptake test that typically lasts between 8-12 minutes
Title
Disparity of subjective exertion and ventilatory efficiency
Description
Regression of ratings of perceived exertion (RPE; Borg scale, minimum value 6 representing no exertion, maximum value 20 representing maximal exertion. Higher scores represent higher perceived exertion) and minute ventilation/carbon dioxide slope (VE/VCO2 slope).
Time Frame
Every minute during the peak oxygen uptake test that typically lasts between 8-12 minutes
Title
Subjective physical activity levels
Description
International Physical Activity Questionnaire (IPAQ). Answers to questions (time spent completing different physical activities) converted to Metabolic Equivalent (METs) hours per week. Minimum value of zero, no limit to maximum. Higher MET values indicate higher physical activity levels.
Time Frame
Prior to experimental trial
Title
Attitudes and beliefs towards physical activity
Description
Barriers to Physical Activity Questionnaire. 21 item questionnaire, each question rated from 0 (very unlikely) to 3 (very likely). Each item belongs to one of 7 categories relating to barriers to physical activity. Score totals greater than 5 indicate the category as being a significant barrier.
Time Frame
Prior to experimental trial
Title
Subjective health related quality of life: RAND 36-Item Short Form Health Survey (SF-36)
Description
RAND 36-Item Short Form Health Survey (SF-36). 36-item questionnaire covering 8 concepts; physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions, plus single item providing an indication of perceived change in health. Scores ranging from 0 to 100 for each concept with 100 indicating good health and 0 being poor health.
Time Frame
Prior to experimental trial
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
For ulcerative colitis patients;
Currently in remission of disease (asymptomatic at time of experiment)
Less than 3 periods of disease activity (periods of symptomatic activity) in the last 12 months
No history of surgery to alleviate condition severity
Taking regular standard medication for control of condition
Adult less than 50 years due to effects of exercise in older age
Non-smokers
Regular exercisers (determined via verbal discussion)
For healthy controls;
No history of disease (as assessed by standard medical screening questionnaire)
Adult less than 50 years due to effects of exercise in older age
Non-smokers
Regular exercisers (determined via verbal discussion)
Exclusion Criteria:
For ulcerative colitis patients;
Currently in active period of disease (symptomatic at time of experiment)
More than 3 periods of disease activity (periods of symptomatic activity) in the last 12 months
History of surgery to alleviate condition severity
Taking non-standard medication for control of condition
Adult more than 50 years of age
Under 18 years of age
Smokers
Sedentary or not regularly physically active (determined via verbal discussion)
For healthy controls;
History of disease (as assessed by standard medical screening questionnaire)
Adult more than 50 years of age
Under 18 years of age
Smokers
Sedentary or not regularly physically active (determined via verbal discussion)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gethin H Evans, PhD
Organizational Affiliation
Manchester Metropolitan University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Adora MW Yau, PhD
Organizational Affiliation
Manchester Metropolitan University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John McLaughlin, Prof.
Organizational Affiliation
University of Manchester
Official's Role
Principal Investigator
Facility Information:
Facility Name
Manchester Metropolitan University
City
Manchester
State/Province
Greater Manchester
ZIP/Postal Code
M1 5GD
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Planned communication of group results at a scientific conference. Planned publication in a scientific peer reviewed journal. Participant level data is not expected to be available as this complies with the conditions of the ethical approval granted for this study.
Learn more about this trial
Effects of Exercise in Patients With Ulcerative Colitis
We'll reach out to this number within 24 hrs